<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CHTP</title>
    <link />
    <description>Headlines for Chelsea Therapeutics International Ltd.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Columbia Wanger Chucks Chelsea, Despite FDA Progress</title>
      <link>http://www.fool.com/news/xt/gurufocus/www.gurufocus.com/news/216118/columbia-wanger-chucks-chelsea-despite-fda-progress.aspx</link>
      <author>GuruFocus</author>
      <pubDate>Tue, 09 Apr 2013 20:19:18 GMT</pubDate>
    </item>
    <item>
      <title>Columbia Wanger Chucks Chelsea, Despite FDA Progress</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/columbia-wanger-chucks-chelsea-despite-fda-progress-cm235278.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 09 Apr 2013 19:06:40 GMT</pubDate>
    </item>
    <item>
      <title>Is Chelsea Therapeutics A Buy After Skyrocketing Up Over 150%?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1326791-is-chelsea-therapeutics-a-buy-after-skyrocketing-up-over-150.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 08 Apr 2013 09:17:25 GMT</pubDate>
    </item>
    <item>
      <title>Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1302731-chelsea-therapeutics-a-shoe-in-for-fda-approval-shares-could-double-from-here.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Mar 2013 21:02:48 GMT</pubDate>
    </item>
    <item>
      <title>4 Stocks Under $10 Making Big Moves</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-stocks-under-10-making-big-moves.html-12.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 21 Mar 2013 15:23:00 GMT</pubDate>
    </item>
    <item>
      <title>Avoid This Biotech Stock</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/15/avoid-this-biotech-stock/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 15 Mar 2013 09:56:00 GMT</pubDate>
    </item>
    <item>
      <title>Why These 4 Biotechs Could Be Next In Line To See Their Share Prices Rise</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1258761-why-these-4-biotechs-could-be-next-in-line-to-see-their-share-prices-rise.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 08 Mar 2013 08:09:21 GMT</pubDate>
    </item>
    <item>
      <title>Tuesday’s biggest gaining and declining stocks</title>
      <link>http://www.fool.com/news/xt/marketwatch/www.marketwatch.com/story/tuesdays-biggest-gaining-and-declining-stocks-2013-02-26.aspx?mod=247wallst</link>
      <author>MarketWatch</author>
      <pubDate>Tue, 26 Feb 2013 08:12:29 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/23/this-week-in-biotech-16/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 23 Feb 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging News at Chelsea - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93222/encouraging-news-at-chelsea.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 21 Feb 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>FDA Whiplashes This Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/fda-whiplashes-this-biotech/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 21 Feb 2013 14:42:00 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Small Cap Movers for Wednesday February 20, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/02/3351789/benzingas-small-cap-movers-for-wednesday-february-20-2013.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Feb 2013 21:37:54 GMT</pubDate>
    </item>
    <item>
      <title>Market Wrap for Wednesday February 20: Stocks Fall as Risks Re-Emerge; VIX up 19%</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/markets/bonds/13/02/3351097/market-wrap-for-wednesday-february-20-stocks-fall-as-risks-re-emerge-vix.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 20 Feb 2013 16:26:31 GMT</pubDate>
    </item>
    <item>
      <title>Chelsea Therapeutics Back on the Map in a Serious Way</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2013/02/20/chelsea-therapeutics-back-on-the-map-in-a-serious-way/.aspx</link>
      <author>247wallst</author>
      <pubDate>Wed, 20 Feb 2013 16:04:57 GMT</pubDate>
    </item>
    <item>
      <title>Chelsea Therapeutics International's CEO Discusses Chelsea Therapeutics Receives FDA Guidance for No</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1208091-chelsea-therapeutics-international-s-ceo-discusses-chelsea-therapeutics-receives-fda-guidance-for-northera-tm-droxidopa-nda-resubmission-with-study-306b-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Feb 2013 15:44:02 GMT</pubDate>
    </item>
    <item>
      <title>FDA Changes Stance, Favors NDA Resubmission For CHTP's Northera</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1206671-fda-changes-stance-favors-nda-resubmission-for-chtp-s-northera.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Feb 2013 11:17:34 GMT</pubDate>
    </item>
    <item>
      <title>Wednesday’s biggest gaining and declining stocks</title>
      <link>http://www.fool.com/news/xt/marketwatch/www.marketwatch.com/story/wednesdays-biggest-gaining-and-declining-stocks-2013-02-20.aspx?mod=247wallst</link>
      <author>MarketWatch</author>
      <pubDate>Wed, 20 Feb 2013 08:53:23 GMT</pubDate>
    </item>
    <item>
      <title>What No One Is Saying About Paramount Biosciences: 3 Case Histories And 4 Companies To Avoid</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1071151-what-no-one-is-saying-about-paramount-biosciences-3-case-histories-and-4-companies-to-avoid.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 18 Dec 2012 13:27:49 GMT</pubDate>
    </item>
    <item>
      <title>The Worst of 2012: Chelsea Therapeutics</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/10/the-worst-stocks-of-2012-chelsea-therapeutics/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 10 Dec 2012 13:58:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Weekly Recap: The Market Holds While Biotech Crumbles</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1053821-biotech-weekly-recap-the-market-holds-while-biotech-crumbles.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 09 Dec 2012 22:16:34 GMT</pubDate>
    </item>
  </channel>
</rss>
